What are the values and preferences of patients with AF regarding VKA therapy, risk of stroke, and risk of bleeding?
Patients with AF have varying values and preferences regarding VKA therapy, risk of stroke, and risk of bleeding. These preferences are affected by factors such as patient age, gender, co-morbidities, and overall quality of life. Research studies such as randomized controlled trials (RCTs) and observational studies can be conducted to better understand the values and preferences of patients with AF regarding anticoagulant therapy. 